Is This Defense Stock Still the Smartest Buy After Its Big Run?

Howmet Aerospace is highlighted as a strong industrial and defense-adjacent stock, with revenue up 48% in commercial aerospace, 39% in gas turbines, and 13% in defense in the latest quarter. The company carries an A- credit rating, net leverage of just 0.9x, double-digit free cash flow margins, and returned $450 million to shareholders in Q1, while its dividend increase streak reached five years. The article is bullish on fundamentals, though it is more a stock commentary than a new catalyst.

Analysis

The market is increasingly treating HWM less like a cyclical aerospace supplier and more like a scarce “picks-and-shovels” compounder on three demand fronts: commercial build rates, defense platform sustainment, and turbines tied to electrification-adjacent capex. That mix matters because it reduces single-end-market drawdown risk while preserving upside from multiple capex cycles that are not perfectly synchronized. The second-order winner is the supply chain underneath HWM: if its content per shipset keeps rising, smaller sub-tier machine shops and specialty materials vendors should see leverage later than the prime contractors, but with less valuation premium.

The key setup is that the stock’s rerating is likely being supported by earnings durability rather than just revenue growth, which means the next leg is probably multiple expansion from quality rather than another step-function in estimates. The risk is that investors are extrapolating high-teens to low-20s growth too far into the cycle; if commercial aerospace normalizes or defense procurement timing slips, HWM can still disappoint on rate of change even if absolute numbers stay healthy. In that scenario, the stock probably de-rates before fundamentals break, so the trade horizon matters more than the story.

The contrarian angle is that HWM is becoming crowded as the “quality defense-industrials” proxy, and crowded quality often gets punished when macro rotates from growth to value or when rates back up. BA and LMT remain structurally weaker narratives, but that is exactly why HWM’s relative outperformance may have less room from here unless the market continues to pay up for balance-sheet strength and capital returns. The better read is that HWM is a good business with a premium multiple, not a hidden value trade; upside likely comes from ongoing estimate revisions, while downside comes from any sign that the market has already priced in flawless execution.

Key Decisions for Investors

• Stay long HWM on a 3-6 month horizon, but size for quality-premium compression; favor add-backs only on post-earnings pullbacks or broad industrial selloffs, targeting a 10-15% upside path versus low-double-digit downside if multiples mean-revert.
• Pair trade: long HWM / short BA for 1-2 quarters to express supplier-quality versus execution-risk divergence; HWM benefits from diversified end markets while BA remains a hostage to program-level disruption and customer confidence.
• For more defense beta, pair long HWM / short LMT only if you want cleaner growth exposure and are willing to give up yield; use a tighter stop because LMT’s valuation can re-rate on budget headlines faster than expected.
• Buy HWM on any 5-8% drawdown triggered by macro/rate fears, not on strength; the best entry is when the market de-risks cyclicals but the company-specific order book remains intact.
• Consider selling out-of-the-money covered calls 1-2 quarters out against existing HWM exposure to harvest premium while limiting upside participation in a crowded-quality name.